Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

NCT06229067 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Triple Negative Breast Cancer

Interventions

DRUG: Adebrelimab
DRUG: Vinorelbine
DRUG: Cyclophosphamide (tablet)
DRUG: Capecitabine

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences